benoxinate has been researched along with Diabetes Mellitus, Type 1 in 1 studies
benoxinate: RN given refers to parent cpd; structure
oxybuprocaine : A benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester "caine") used especially in ophthalmology and otolaryngology.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stolwijk, TR | 1 |
| van Best, JA | 1 |
| Boor, JP | 1 |
| Lemkes, HH | 1 |
| Oosterhuis, JA | 1 |
1 other study available for benoxinate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Corneal epithelial barrier function after oxybuprocaine provocation in diabetics.
Topics: Adolescent; Adult; Aged; Cornea; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Epithelium; F | 1990 |